Admission Date:  [**2192-5-18**]              Discharge Date:   [**2192-5-24**]   Service: CARDIOTHORACIC  Allergies: Iodine Containing Agents Classifier / Heparin Agents  Attending:[**First Name3 (LF) 1283**] Chief Complaint: Patient returned from [**Hospital3 **] after UE ultrasound revealed LUE DVT involving entire subclavian.
Patient is HIT+ and required tx w/Argatroban and therefore returned to [**Hospital1 18**] for tx  Major Surgical or Invasive Procedure: none   History of Present Illness: s/p Asc Ao replacemnt [**4-24**], after complicated postop course transferred to [**Hospital3 **] [**5-17**].
Returned to [**Hospital1 18**] [**5-18**] for tx of UE DVT with Argatroban and Coumadin  Past Medical History: HTN hypercholesterolemia R fem AV fistula anxiety/depression osteoporosis varicose veins h/o R ankle fx hard-of-hearing  Social History: 3 sons.
PEG in place Ext: Warm no pedal edema, + left arm edema  Discharge VS 98.6  81SR  142/50  18  100% on 40%TM Gen: NAD Neuro: Alert, responsive follows commands CV: RRR, sternum stable wound CDI Pulm: scattered rhonchi w/productive cough Abdm: soft +BS/PEG site CDI Ext: Warm no pedal edema, 1+ LUE edema  Pertinent Results: [**2192-5-17**] 04:48AM   GLUCOSE-187* UREA N-28* CREAT-0.7 SODIUM-145 POTASSIUM-4.4 CHLORIDE-110* TOTAL CO2-27 ANION GAP-12 [**2192-5-17**] 04:48AM   WBC-9.5 RBC-3.68* HGB-10.6* HCT-32.9* MCV-89 MCH-28.7 MCHC-32.2 RDW-15.1 [**2192-5-17**] 04:48AM   PLT COUNT-291 [**2192-5-24**] 08:40AM BLOOD PT-21.1* PTT-41.1* INR(PT)-2.0*  Brief Hospital Course: Admitted to [**Hospital1 18**] [**5-18**] from [**Hospital3 **] for tx of UE DVT in HIT+ patient w/Argatroban and transition to Warfarin.
Pt begun on Argatroban shortly after arrival at [**Hospital1 18**].
The patient was also begun on Warfarin and dose was titrated up while maintaining Argatroba infusion until [**5-24**] pt had therapeudic INR and Argatroban infusion was stopped.
Her transfer medications  were continued unchanged.
The patient was also begun on Glipizide for persistantly elevated blood glucose levels.
Her blood sugars will need to be monitored for additional dose adjustments.
Medications on Admission: lorazepam 1mg QID/PRN Nystatin Susp QID Ca Acetate 667mg TID Albuterol MDI 2P Q@/PRN Metoprolol 100 [**Hospital1 **] Lisinopril 10 QD Lansoprazole 30mg QD Norvasc 10 QD Amiodarone 200 QD Dlantin 100 TID Simvastatin 80 QD ASA 325 QD tylenol 650 Q6/PRN  Discharge Medications: 1.
Aspirin 325 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).
Miconazole Nitrate 2 % Powder Sig: One (1) Appl Topical  QID (4 times a day) as needed.
Atorvastatin 40 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).
Amiodarone 200 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).
Amlodipine 5 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).
Lansoprazole 30 mg Susp,Delayed Release for Recon Sig: Thirty (30) mg PO DAILY (Daily).
Lisinopril 5 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).
Metoprolol Tartrate 50 mg Tablet Sig: Two (2) Tablet PO BID (2 times a day).
Phenytoin 100 mg/4 mL Suspension Sig: Five (5) ml PO Q8H (every 8 hours): 125mg/TID.
Trazodone 50 mg Tablet Sig: 0.5 Tablet PO HS (at bedtime) as needed.
Glyburide 5 mg Tablet Sig: One (1) Tablet PO BID (2 times a day).
Warfarin 2 mg Tablet Sig: as directed Tablet PO once a day: 5mg [**5-24**] then as directed to maintain target INR 2-2.5.
Furosemide 20 mg Tablet Sig: One (1) Tablet PO twice a day.
Discharge Disposition: Extended Care  Facility: [**Hospital6 85**] - [**Location (un) 86**]  Discharge Diagnosis: s/p Asc Ao Aneurysm repair CVA DVT Lft UE, Tx w/Argatroban and Coumadin HIT+ s/p retroperitoneal bleed s/p Trach/PEG PMH: HTN,^choldepression, Anxiety, Osteoporosis, Varicose veins   Discharge Condition: good   Discharge Instructions: keep wounds clean and dry.
Take all medications as prescribed.
